A hormone blocker is any medication that either stops the body from producing a specific hormone or prevents that hormone from doing its job. These drugs work by interfering with the chemical signals that hormones use to influence cells, and they’re used to treat a wide range of conditions, from breast and prostate cancer to overactive thyroid, hormonal acne, and gender dysphoria in adolescents.
The term “hormone blocker” isn’t one single drug. It’s an umbrella that covers dozens of medications, each targeting a different hormone through a different mechanism. What they share is a common strategy: cut off a hormone’s influence on the body, either by reducing its supply or by blocking its ability to reach the cells it normally acts on.
How Hormone Blockers Work
Hormones act like keys that fit into specific locks, called receptors, on the surface of cells. When a hormone binds to its receptor, it triggers a chain of activity inside the cell. Hormone blockers disrupt this process in one of two fundamental ways.
The first approach is receptor blocking. These drugs occupy the receptor site so the hormone can’t attach. The hormone is still circulating in the blood, but it’s effectively locked out. Tamoxifen, used in breast cancer treatment, works this way: it sits in the estrogen receptor on cancer cells, preventing estrogen from fueling their growth. Anti-androgen medications used for prostate cancer do the same thing with testosterone receptors.
The second approach is synthesis inhibition, which means stopping the body from making the hormone in the first place. Rather than blocking the lock, these drugs eliminate the key. Aromatase inhibitors, for example, shut down an enzyme responsible for the final step of estrogen production. At standard doses, they reduce circulating estrogen to undetectable levels in many patients. Antithyroid medications use a similar strategy, blocking the chemical reactions the thyroid gland needs to build its hormones.
Some treatments combine both approaches, or use a third route: signaling the brain to stop triggering hormone production. GnRH analogues, for instance, override the brain’s hormonal signaling system so the pituitary gland stops telling the body to make sex hormones. This single mechanism is used in prostate cancer, certain breast cancers, and puberty-delaying treatment for adolescents.
Hormone Blockers in Breast Cancer
About two-thirds of breast cancers have receptors for estrogen, meaning the hormone actively drives tumor growth. For these cancers, hormone blockers are a cornerstone of treatment, often taken for years after surgery to reduce the chance of the cancer returning.
There are two main categories. Receptor blockers like tamoxifen physically prevent estrogen from docking with cancer cells. It’s taken as a daily pill and is used in both premenopausal and postmenopausal women. Fulvestrant, another receptor blocker, is given as a monthly injection and is typically reserved for cancer that has spread.
Aromatase inhibitors take the other route, slashing estrogen production throughout the body. These are daily pills used primarily in postmenopausal women, since before menopause the ovaries produce too much estrogen for these drugs to fully suppress. The standard treatment course is at least five years. A large meta-analysis of over 22,000 postmenopausal women found that extending aromatase inhibitor treatment to ten years reduced the risk of distant cancer recurrence by roughly 25% compared to stopping at five years. Whether that extended course is worthwhile depends on the individual’s cancer risk and how well they tolerate the medication, which is why guidelines still vary on the optimal duration.
Hormone Blockers in Prostate Cancer
Prostate cancer is driven by androgens, primarily testosterone. Hormone therapy for prostate cancer aims to cut testosterone levels or block its effects, and there are several ways to do it.
The most common starting point is androgen deprivation therapy, which reduces testosterone production by 90% to 95%. This can be done surgically by removing the testicles, but more often it’s done with medications that manipulate the brain’s hormonal control system. GnRH agonists, given as injections every one to six months, initially cause a brief surge in testosterone before shutting production down. GnRH antagonists skip the surge and suppress testosterone immediately. One GnRH antagonist, relugolix, is available as a daily pill rather than an injection.
Androgen receptor blockers add another layer by preventing whatever testosterone remains from reaching cancer cells. Second-generation versions of these drugs bind to the androgen receptor more tightly and specifically than older options, making them more effective at starving cancer cells of hormonal fuel. These are taken as daily pills.
A third class, androgen synthesis inhibitors, blocks an enzyme needed to produce testosterone not just in the testicles but also in the adrenal glands and in tumor tissue itself. These lower testosterone more completely than any other available treatment.
Puberty Blockers
In gender-affirming care for adolescents, GnRH analogues are used to pause puberty. These are the same class of drugs used in cancer treatment, but in this context they prevent the pituitary gland from triggering the production of sex hormones that drive puberty’s physical changes.
Puberty blockers are not started before puberty begins. They’re used once puberty is underway, in adolescents who have a sustained pattern of gender dysphoria, have addressed any related psychological or social concerns, and have provided informed consent. The medication is typically given as a shot monthly, every three months, or every six months, or as a small implant under the skin of the upper arm that’s replaced yearly.
The effects are considered largely reversible. If the medication is stopped, puberty resumes. If the adolescent continues with gender-affirming care, puberty blockers serve as a bridge, giving them more time before decisions about further hormonal treatment.
Other Conditions Treated With Hormone Blockers
Overactive Thyroid
When the thyroid gland produces too much hormone, antithyroid medications block the chemical steps the gland uses to build those hormones. Methimazole works by preventing the thyroid from using iodine, a raw material it needs for hormone production. Another option, propylthiouracil, does the same thing and also blocks the conversion of one thyroid hormone into its more active form, providing a dual effect. Potassium iodide takes a different approach, inhibiting the release of thyroid hormones that have already been made.
Hormonal Acne
Androgens like testosterone stimulate oil production in the skin. When androgen levels are high, the excess oil clogs pores and leads to breakouts, particularly along the jawline and chin. Spironolactone, originally developed as a blood pressure medication, also reduces androgen activity. At doses as low as 50 mg per day (the range runs from 25 to 200 mg), it can significantly improve hormonal acne by cutting the oil production that feeds it.
Side Effects of Lowering Hormones
Because hormone blockers reduce the activity of hormones that affect the entire body, side effects tend to reflect what happens when those hormones are absent or diminished. The specific side effects depend on which hormone is being blocked.
Estrogen blockers and aromatase inhibitors commonly cause hot flashes, joint pain, and fatigue. Over time, lower estrogen levels can reduce bone density, increasing the risk of fractures. This is a particular concern with aromatase inhibitors taken for five or more years, and bone health monitoring is a routine part of treatment.
Testosterone-lowering therapies can cause hot flashes, reduced sex drive, erectile dysfunction, fatigue, loss of muscle mass, and weight gain. Long-term androgen deprivation also carries risks to bone density and may affect cardiovascular health and mood.
Puberty blockers can affect bone mineral density during treatment, since sex hormones play a key role in building bone during adolescence. Antithyroid medications can occasionally cause liver problems or a drop in white blood cell count, though these are uncommon.
The severity of side effects varies widely from person to person. For many of the cancer-related uses, the benefits of reducing recurrence or slowing tumor growth substantially outweigh the risks. For non-cancer uses, the lower doses involved generally produce milder side effects.
How They’re Taken
Hormone blockers come in several forms, and the method of delivery often depends on the type of drug and the condition being treated. Many are daily pills taken at home: tamoxifen, aromatase inhibitors, anti-androgens, antithyroid medications, and spironolactone all fall into this category. Injectable options, like GnRH agonists and antagonists, are administered by a healthcare professional anywhere from once a month to once every six months. Some are available as implants placed under the skin and replaced annually. Fulvestrant is given as a monthly injection after an initial loading period.
Treatment duration ranges from months to years. Aromatase inhibitors for breast cancer are taken for a minimum of five years, sometimes ten. Androgen deprivation for prostate cancer may continue indefinitely in advanced cases. Puberty blockers are used until the adolescent and their care team decide on next steps. Antithyroid medications are often taken for 12 to 18 months, though some people need longer courses.